TY  - JOUR
AU  - Moik, Florian
AU  - Colling, Meaghan
AU  - Mahé, Isabelle
AU  - Jara-Palomares, Luis
AU  - Pabinger, Ingrid
AU  - Ay, Cihan
PY  - 2021
DO  - 10.1111/jth.15599
UR  - http://hdl.handle.net/10668/20002
T2  - Journal of thrombosis and haemostasis : JTH
AB  - Patients with cancer-associated venous thromboembolism (VTE) are recommended to receive treatment with therapeutic anticoagulation for at least 3-6 months. Little data exist on extended treatment beyond 6 months. To comprehensively summarize the best...
LA  - en
KW  - anticoagulants
KW  - hemorrhage
KW  - neoplasms
KW  - venous thromboembolism
KW  - venous thrombosis
KW  - Anticoagulants
KW  - Hemorrhage
KW  - Humans
KW  - Neoplasms
KW  - Randomized Controlled Trials as Topic
KW  - Recurrence
KW  - Venous Thromboembolism
KW  - Venous Thrombosis
TI  - Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review.
TY  - research article
VL  - 20
ER  -